May & Baker Nigeria Plc (MAYBAKER)
About
May & Baker Nigeria Plc is a Nigerian pharmaceutical company that manufactures and markets a wide range of pharmaceutical products, including antibiotics, antimalarials, and analgesics.
No Asset Insights Available
There’s no available data for this asset at the moment.
Earnings Per Share (EPS)
3.16
The net profit divided by number of shares TTM
Price to Earnings (P/E)
13.07
Current price divided by EPS
Observed Effective Yield
56%
Observed annual compounding rate (5y)
Dividend Yield: 3.09%
1% Payments Since Sep 28th
Dividend history found below or visit Dividend Corner page
Risk Exposure
56.21%
Observed Likelihood of Downside Risk
Risk-Return Ratio
0.91%
You want this to be as low as possible
Periodic Returns
Performance over fixed intervals
DOD(Last Day)
0.00%
WTD(This Week)
5.90%
WOW(One Week)
5.90%
MTD(This Month)
11.62%
MOM(One Month)
11.62%
QTD(This Quarter)
3.25%
QOQ(One Quarter)
3.25%
YTD(This Year)
117.37%
YOY(One Year)
154.15%
AI-Powered Analysis
Our proprietary engine has identified key patterns and trends for MAYBAKER.Sign in to unlock comprehensive analysis and actionable recommendations.
Price Statistics
Analysis from Sep 29, 2025 to Present
Starting
₦16.2
Period High
₦52
Period Low
₦15.7
Current
₦41.3
Price Percentile
70.52%
